What did we do well in the first year of pandemic (H1N1) 2009, and what can we do better?
In Mexico in April 2009, a new H1N1 influenza strain appeared to be associated with a high mortality rate. This fuelled fears that a highly virulent virus would quickly spread internationally and cause millions of deaths. Appropriately heightened surveillance and controls were put in place, and Australia activated its “well-rehearsed plan for response to pandemic influenza”.1 Across the country by mid May, we had in place accurate polymerase chain reaction (PCR) testing for “swine flu”, improved public awareness of infection control and good public health surveillance. By September, Australia was among the first countries with a vaccine available. Now, a year after the virus first emerged, what have we learnt and how could our pandemic response be improved in the future?
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 2009; 361: 2591-2594.
- 2. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection — California, April–May, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 536-541.
- 3. Australian Government Department of Health and Ageing. National tally of confirmed cases of H1N1 influenza 09, as at 5am, 21st June 2009. http://www.health.gov.au/internet/healthemergency/publishing.nsf/Content/87EACFF5730CFA33CA25761C00042589/$File/H1N1% 20Influenza%2009%205am%2021%20June.doc (accessed Feb 2010).
- 4. Australian Government Department of Health and Ageing. Australian influenza surveillance summary report. No. 3, 2010, reporting period: 16 January 2010 – 22 January 2010. http://www.health.gov.au/internet/healthemergency/publishing.nsf/Content/ozflu2010.htm/$File/ozflu-no3-2010.pdf (accessed Feb 2010).
- 5. Doshi P. Calibrated response to emerging infections. BMJ 2009; 339: b3471. doi: 10.1136/bmj.b3471.
- 6. Centers for Disease Control and Prevention (CDC). Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States — early, targeted, layered use of nonpharmaceutical interventions. Atlanta: CDC, 2007. http://www.flu.gov/professional/community/mitigation.html (accessed Feb 2010).
- 7. Google.org. Google flu trends [website]. http://www.google.org/flutrends (accessed Feb 2010).
- 8. Kelly HA. A pandemic response to a disease of predominantly seasonal intensity. Med J Aust 2010; 192: 81-83. <MJA full text>
- 9. Newall AT, Wood JG, Macintyre CR. Influenza-related hospitalisation and death in Australians aged 50 years and older. Vaccine 2008; 26: 2135-2141.
- 10. Gordon CL, Johnson PD, Permezel M, et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 2010; 50: 672-678.
- 11. Jefferson T, Jones M, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2010; (2): CD001265.
- 12. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361: 2405-2413.
- 13. Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010; 303: 37-46.
- 14. Demicheli V, Di Pietrantonj C, Jefferson T, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007; (2): CD001269. DOI: 10.1002/14651858.CD001269.pub3. http://www3.interscience.wiley.com/homepages/106568753/CD001269_standard.pdf (accessed Feb 2010).
- 15. Eizenberg P. The general practice experience of the swine flu epidemic in Victoria — lessons from the front line. Med J Aust 2009; 191: 151-153. <MJA full text>
- 16. Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2010; (1): CD006207.
- 17. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: 962-970.
Canberra Hospital, and my microbiology laboratory at the hospital, received public health funds to do additional pandemic (H1N1) 2009 testing.